These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9031290)

  • 1. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Shapiro MD; Kelleher SP
    Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.
    Mörsdorf S; Köhler M; Leipnitz G; Wenzel E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.
    Khair K; Baker K; Mathias M; Burgess C; Liesner R
    Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy for uremic bleeding.
    Sloand JA
    Int J Artif Organs; 1996 Aug; 19(8):439-40. PubMed ID: 8841839
    [No Abstract]   [Full Text] [Related]  

  • 9. DDAVP therapy controls bleeding in Ehlers-Danlos syndrome.
    Stine KC; Becton DL
    J Pediatr Hematol Oncol; 1997; 19(2):156-8. PubMed ID: 9149748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis following desmopressin for uremic bleeding.
    Byrnes JJ; Larcada A; Moake JL
    Am J Hematol; 1988 May; 28(1):63-5. PubMed ID: 3259400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic and fibrinolytic response to desmopressin in uremic patients.
    Chen KS; Huang CC; Leu ML; Deng P; Lo SK
    Blood Purif; 1997; 15(2):84-91. PubMed ID: 9087815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulo-fibrinolytic response to intranasal administration of low dose desmopressin acetate (DDAVP) in normal and hemophiliac subjects].
    Kakishita E; Uomoto M; Nishida K; Hara M; Nagai K
    Rinsho Byori; 1982 Nov; 30(11):1230-4. PubMed ID: 7182595
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
    Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
    Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWEET, the Swedish Enuresis Trial.
    Hjälmås K
    Scand J Urol Nephrol Suppl; 1995; 173():89-92; discussion 93. PubMed ID: 8719576
    [No Abstract]   [Full Text] [Related]  

  • 15. Desmopressin 120 mcg, 180 mcg, 240 mcg: The right treatment for the right patient.
    Ferrara P; Del Vescovo E; Ianniello F; Franceschini G; Romaniello L; Verrotti A
    Arch Ital Urol Androl; 2018 Jun; 90(2):127-129. PubMed ID: 29974730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding in renal failure.
    Remuzzi G
    Lancet; 1988 May; 1(8596):1205-8. PubMed ID: 2897015
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of response to desmopressin in children and adolescents with monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Skoog S; Zaontz MR; Sihelnik S
    Scand J Urol Nephrol Suppl; 1995; 173():109-10; discussion 110-1. PubMed ID: 8719580
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. How effective is desmopressin for primary nocturnal enuresis?
    Diehr S; Scoville C; Bercaw DM
    J Fam Pract; 2003 Jul; 52(7):568-9. PubMed ID: 12841976
    [No Abstract]   [Full Text] [Related]  

  • 19. Are repeated desmopressin treatment attempts successful?
    Wikström S; Tapper J
    Scand J Urol Nephrol Suppl; 1997; 183():33-4; discussion 34-5. PubMed ID: 9165603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of desmopressin in children with coagulation disorders.
    Brown OE
    Int J Pediatr Otorhinolaryngol; 1986 Sep; 11(3):301-5. PubMed ID: 3771110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.